GL1X · GenesisL1 explorer

MolNFT v1 · #93970 · protein

The structure of V122I mutant transthyretin in complex with AG10

4HIQ: “The structure of V122I mutant transthyretin in complex with AG10”. X-ray diffraction, 1 ligand (16V), 3 pockets (best druggability 0.32). MolNFT v1 #93970 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4HIQ
Type
protein
Length
231 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
16V
Pockets
3 · best druggability 0.32

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1166% helix, 51% strandP02766
BTransthyretinprotein1156% helix, 52% strandP02766

Ligands and binding sites

  • 16V · 3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluorobenzoic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1560.320.7614empty
2630.300.7515empty
3550.250.7323empty

Interfaces

1 interface between chains.

  • A–B · 926 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 4HIQ · The Structure of V122I Mutant Transthyretin in Complex with AG10 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.